Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4673954017 | Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4673955016 | Bambuterol hydrochloride 10 mg and montelukast (as montelukast sodium) 10 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5300701000052119 | bambuterolhydroklorid 10 mg och montelukast (som montelukastnatrium) 10 mg, oral tablett | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Bambuterol and montelukast only product in oral dose form | true | Inferred relationship | Some | ||
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Montelukast sodium | true | Inferred relationship | Some | 1 | |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Montelukast (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Bambuterol hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Bambuterol hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets